Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  225 نتائج ل ""tenofovir alafenamide""

فلترة النتائج

Subject : anti-hiv agents
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.

  • Authors : Merchant E; Department of Medicine, Tufts Medical Center, Boston, MA, United States of America.; Tufts University School of Medicine, Boston, MA, United States of America.

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: PloS one [PLoS One] 2024 Dec 05; Vol. 19 (12), pp. e0311591. Date of Electronic Publication: 2024 Dec 05 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV.

  • Authors : Lee SY; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan.; Lin YC

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; Pyridones*/Pyridones*/Pyridones*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Nov 20; Vol. 19 (11), pp. e0314003. Date of Electronic Publication: 2024 Nov 20 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta-analysis.

  • Authors : Yoo JJ; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.; Jung EA

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/adverse effects

  • Source: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Sep; Vol. 27 (9), pp. e26358.Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Renal safety of tenofovir alafenamide-based antiretroviral therapy in people with HIV: A mini-review.

  • Authors : Zhao F; National Clinical Research Centre for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China.; Lu H

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/adverse effects ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: Bioscience trends [Biosci Trends] 2024 Jun 06; Vol. 18 (2), pp. 141-152. Date of Electronic Publication: 2024 Apr 24.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis.

  • Authors : Massih SA; Division of Clinical Pharmacology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Atta MG

Subjects: Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/pharmacokinetics ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/therapeutic use ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/adverse effects

  • Source: AIDS research and therapy [AIDS Res Ther] 2024 May 21; Vol. 21 (1), pp. 34. Date of Electronic Publication: 2024 May 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101237921 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-6405

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Tenofovir alafenamide plus dolutegravir as a switch strategy in HIV-infected patients: a pilot randomized controlled trial.

  • Authors : Alavian G; Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.; Abbasian L

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/drug therapy ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use

  • Source: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences [Daru] 2023 Dec; Vol. 31 (2), pp. 145-153. Date of Electronic Publication: 2023 Aug 04.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101125969 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Treatment-emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series.

  • Authors : DeKoven S; Department of Family and Community Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.; Naccarato M

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/pharmacology ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use

  • Source: HIV medicine [HIV Med] 2023 Nov; Vol. 24 (11), pp. 1137-1143. Date of Electronic Publication: 2023 Jun 14.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/adverse effects; Male

  • Source: PloS one [PLoS One] 2023 Aug 09; Vol. 18 (8), pp. e0289132. Date of Electronic Publication: 2023 Aug 09 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV.

  • Authors : Devred I; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, 184 Rue du Faubourg Saint-Antoine, F75571, Cedex 12, Paris, France. .; Kayembe K

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/therapeutic use ; Drug-Related Side Effects and Adverse Reactions* ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy

  • Source: BMC infectious diseases [BMC Infect Dis] 2023 Sep 04; Vol. 23 (1), pp. 578. Date of Electronic Publication: 2023 Sep 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effectiveness, durability and safety of dolutegravir and lamivudine versus bictegravir, emtricitabine and tenofovir alafenamide in a real-world cohort of HIV-infected adults.

  • Authors : Mendoza I; Pharmacy Department, Hospital Universitario de Guadalajara, Guadalajara, Spain.; Alcalá University, Alcalá de Henares, Spain.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/adverse effects; Humans

  • Source: PloS one [PLoS One] 2023 Sep 29; Vol. 18 (9), pp. e0291480. Date of Electronic Publication: 2023 Sep 29 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  225 نتائج ل ""tenofovir alafenamide""